Vycor Medical (VYCO) Free Cash Flow (2010 - 2026)
Vycor Medical's (VYCO) quarterly Free Cash Flow came in at $99422.0 in Q1 2026, up 469.47% year-on-year from $17458.5 in Q1 2025, and up 164.23% on a QoQ basis from $37627.0 in Q4 2025.
Vycor Medical (VYCO) Free Cash Flow (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Free Cash Flow data on file, last reported at $99422.0 in Q1 2026.
- On a quarterly basis, Free Cash Flow rose 469.47% year-over-year to $99422.0 in Q1 2026; TTM through Mar 2026 was $111254.0, a 255.26% increase from a year earlier, with the FY2025 full-year figure at -$18695.0, down 134.15% from the prior year.
- Free Cash Flow for Q1 2026 stood at $99422.0, up from $37627.0 in the prior quarter.
- Over the last five years, Free Cash Flow for VYCO reached as high as $99422.0 in Q1 2026 and fell as low as -$78780.0 in Q1 2022.
- Historically, Free Cash Flow has averaged -$2859.7 across 5 years, with a median of -$396.0 in 2023.
- On a YoY basis, Free Cash Flow climbed as much as 507.41% in 2024 and fell as far as 9566.41% in 2024.
- Year by year, Free Cash Flow stood at -$33032.0 in 2022, then soared by 98.8% to -$396.0 in 2023, then sank by 9566.41% to -$38279.0 in 2024, then jumped by 198.3% to $37627.0 in 2025, then surged by 164.23% to $99422.0 in 2026.
- Per Business Quant data, the three most recent Free Cash Flow figures were $99422.0 in Q1 2026, $37627.0 in Q4 2025, and -$72428.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | 99,422.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99,422.00 |
| Mar 31, 2026 | 99,422.00 |
| Dec 31, 2025 | 37,627.00 |
| Dec 31, 2025 | 37,627.00 |
| Sep 30, 2025 | -72,428.00 |
| Sep 30, 2025 | -72,428.00 |
| Jun 30, 2025 | 46,633.00 |
| Jun 30, 2025 | 46,633.00 |
| Mar 31, 2025 | -26,909.00 |
| Mar 31, 2025 | -26,909.00 |
| Dec 31, 2024 | -38,279.00 |
| Dec 31, 2024 | -38,279.00 |
| Sep 30, 2024 | 10,470.00 |
| Sep 30, 2024 | 10,470.00 |
| Jun 30, 2024 | 86,034.00 |
| Jun 30, 2024 | 86,034.00 |
| Mar 31, 2024 | 1,887.00 |
| Mar 31, 2024 | 1,887.00 |
| Dec 31, 2023 | -396.00 |
| Dec 31, 2023 | -396.00 |